J.B. Chemicals CEO Nikhil Chopra Resigns
New Delhi: J.B. Chemicals & Pharmaceuticals Limited has announced that its Chief Executive Officer (CEO) and Whole-time Director, Nikhil Chopra, has ceased to hold office effective from the close of business hours on March 31, 2026, following his resignation.
The company had earlier informed about Chopra’s resignation as Whole-time Director after the Board meeting held on January 21, 2026, and as CEO effective March 31, 2026. With this, he has also ceased to be a Key Managerial Personnel of the company.
According to the disclosure, the resignation is attributed to personal reasons and Chopra’s decision to pursue other professional opportunities. He confirmed that there are no other reasons for stepping down apart from those stated.
In his resignation letter, Chopra expressed gratitude towards the Board and management for their support during his tenure and described his experience at the company as a “wonderful journey.” He also requested the company to complete all necessary statutory formalities, including filings with the Registrar of Companies and other authorities, to give effect to his resignation.
The resignation as Whole-time Director became effective upon conclusion of the Board meeting in January 2026, while his role as CEO continued until March 31, 2026.
The company disclosed that the change in key managerial personnel is in line with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and relevant SEBI circulars.
J.B. Chemicals & Pharmaceuticals has taken the resignation on record and will proceed with required compliance and regulatory filings.
